Harrow
HROW
30.62
+0.27
+0.89%
Harrow
US · HROW
#3155 by market cap
30.62
+0.27
+0.89%
Live - 5344 symbols - heartbeat 529s ago
· 2026-10-08 09:03
Pre-market
30.55
-0.23%
After-hours
31.12
+1.63%
Overnight
30.69
+0.23%
- Market cap
- 1.15B
- P/E (TTM)i
- -30.93
- P/Bi
- 75.60
- EPSi
- -0.14
- Div yieldi
- 0.00%
- 52W posi
- 8%
Reader sentiment
Are you bullish or bearish on HROW?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Accumulating
- The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
- Total institutional ownership rose 0.2 percentage points.
Institutional ownership
- Held by institutions
- 58.61% +0.16pp
- Institutions
- 261 -1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund39.49%
Individual/Insider16.43%
Hedge Fund13.10%
VC/PE Fund2.61%
Private Company1.39%
Public Company1.11%
Government Pension Fund0.57%
Insurance Company0.22%
Family Office/Trust0.13%
Other24.97%
Top holders as of 2026-05-14
Mark Baum
7.99% · 3.00M sh
BlackRock
7.31% · 2.74M sh
Opaleye Management Inc.
6.40% · 2.40M sh
Daniel Kaufman
5.01% · 1.88M sh
Vanguard Capital Management, LLC
4.41% · 1.65M sh
Private Capital Management, LLC
4.26% · 1.60M sh
Deep Track Capital, LP
2.58% · 969.00K sh
State Street Global Advisors
2.51% · 939.89K sh
Geode Capital Management, LLC
2.42% · 905.56K sh
Andrew Boll
2.17% · 814.68K sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 32 buys · 18 sells
| Name | Role | Stake |
|---|---|---|
| Mark Baum | Chairperson & CEO | 7.99% |
| Andrew Boll | Chief Financial Officer | 2.17% |
| John Saharek | Chief Commercial Officer | 1.25% |
| Adrienne Graves | Director | 0.00% |
| Lauren Silvernail | Director | 0.00% |
| Opaleye Management Inc. | -- | -- |
| Amir Shojaei | Chief Scientific Officer | -- |
| Perry Sternberg | Independent Director | -- |
| Randall Pollard | Chief Accounting Officer | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-13 | Amir Shojaei | Chief Scientific Officer | Derivative Exercise and Sale | -11,250 | $35.96–40.00 |
| 2026-06-17 | Adrienne Graves | Director | Other Derivative Acquisition | +5,248 | -- |
| 2026-06-17 | Lauren Silvernail | Director | Other Derivative Acquisition | +5,248 | -- |
| 2026-06-17 | Perry Sternberg | Independent Director | Other Derivative Acquisition | +5,248 | -- |
| 2026-05-17 | Adrienne Graves | Director | Open Market Acquisition | +1,000 | $31.07 |
| 2026-05-17 | Lauren Silvernail | Director | Open Market Acquisition | +1,000 | $31.00 |
| 2026-05-14 | Amir Shojaei | Chief Scientific Officer | Other Derivative Acquisition | +10,000 | -- |
| 2026-05-13 | Mark Baum | Chairperson & CEO | Open Market Acquisition | +10,000 | $30.20 |
| 2026-05-13 | Andrew Boll | Chief Financial Officer | Open Market Acquisition | +3,500 | $29.90 |
| 2026-03-03 | Opaleye Management Inc. | -- | Open Market Disposition | -198,572 | $39.15–39.67 |
| 2026-02-26 | Opaleye Management Inc. | -- | Open Market Disposition | -5,000 | $54.18 |
| 2026-01-05 | Opaleye Management Inc. | -- | Open Market Disposition | -20,000 | $53.35 |
| 2025-12-11 | Mark Baum | Chairperson & CEO | Derivative Exercise and Sale | -79,994 | $3.95–47.06 |
| 2025-12-11 | Mark Baum | Chairperson & CEO | Derivative Exercise and Retained | +100,006 | $3.95 |
| 2025-12-11 | Andrew Boll | Chief Financial Officer | Derivative Exercise and Sale | -26,665 | $3.95–47.06 |
| 2025-12-11 | Andrew Boll | Chief Financial Officer | Derivative Exercise and Retained | +33,335 | $3.95 |
| 2025-08-31 | Randall Pollard | Chief Accounting Officer | Other Derivative Acquisition | +30,000 | $39.00 |
| 2025-07-20 | Mark Baum | Chairperson & CEO | Derivative Exercise and Sale | -313,338 | $7.87–37.08 |
| 2025-07-20 | Mark Baum | Chairperson & CEO | Derivative Exercise and Retained | +286,662 | $7.87 |
| 2025-06-30 | Mark Baum | Chairperson & CEO | Other Derivative Acquisition | +889,500 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 09:03:56 · For reference only, not investment advice and not tailored to your situation.